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Edited by Richard MaraisAbstract Serotonin activates Ras and Ras-dependent ERK1/2
phosphorylation in HEK293 cells expressing Gs-coupled 5-HT4
or 5-HT7 serotonin receptors through unknown mechanisms.
Both Epac/Rap-dependent and -independent pathways for Ras-
dependent ERK1/2 activation have been suggested. Epac overex-
pression or Epac-speciﬁc 8-CPT-2 0-O-Me-cAMP did not cause
ERK1/2 phosphorylation, despite Rap activation. The data did
not support a role for PLCe or DAG-dependent Ras GEFs of
the Ras-GRP family in Ras-dependent ERK1/2 phosphorylation.
However, serotonin stimulated phosphorylation of endogenous
and recombinant Ras-GRF1, increased [Ca2+]i and caused
Ca2+- and calmodulin-dependent ERK1/2 phosphorylation. Dif-
ferent signalling pathways seem to be utilised by Gs-coupled
receptors in various isolates of HEK293 cells.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Gprotein-coupled receptors (GPCRs) coupling to the hetero-
trimeric G protein Gs can induce Ras-dependent activation of
the mitogen-activated protein (MAP) kinases ERK1 and
ERK2 (ERK1/2) [1,2]. Activation of Ras family small G pro-
teins is catalysed by speciﬁc guanine nucleotide exchange fac-
tors (GEFs). The Ras-activated ERK1/2 cascade, including
the kinases Raf,MEK andERK1/2, is one of the best character-
ised, but still not fully understood cellular signalling pathways.
Ras and the ERK1/2 cascade is primarily activated by recep-
tor tyrosine kinases (RTKs), e.g. the epidermal growth factor
(EGF) receptor, via the ubiquitous mammalian Ras GEF SonAbbreviations: 5-HT, 5-hydroxytryptamine (serotonin); b2-AR, b2-ad-
renergic receptor; CAI, 5-amino-1-((3,5-dichloro-4-(4-chloro-
benzoyl)phenyl)methyl)-1H-1,2,3-triazole-4-carboxamide; CaM,
calmodulin; EGF, epidermal growth factor; Epac, exchange protein
directly activated by cAMP; ERK, extracellular signal-regulated
kinase; GEF, guanine nucleotide exchange factor; GPCR, G protein-
coupled receptor; HEK, human embryonic kidney; MAP, mitogen-
activated protein
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doi:10.1016/j.febslet.2006.11.069of Sevenless 1 (Sos1), but can also be activated throughGPCRs,
which may utilise diverse signalling pathways to activate
numerous GEFs [3]. Gi- andGq-coupled receptors may transac-
tivate RTKs and thereby Ras and ERK1/2 [4], or activate Ras
GEFs of the Ras-GRF or Ras-GRP (CalDAG-GEF) families,
dependent on Ca2+ or Ca2+ and diacylglycerol (DAG), respec-
tively [5–7]. Gs-coupled receptors may mediate both Ras-
dependent and -independent ERK1/2 activation [1,2,8,9].
Gs-coupled receptors activate adenylyl cyclase and increase
intracellular cAMP, which can activate protein kinase A
(PKA) and Rap-speciﬁc exchange proteins directly activated
by cAMP (Epacs) [10,11]. In some cells, Ras-independent
ERK1/2 activation by Gs-coupled b2-adrenoceptors (b2-AR)
depends on Rap1 [8,9]. However, several studies found no role
for Rap1 in ERK1/2 activation following stimulation of Gs-
coupled receptors [1,2,12]. Recently, a Ras-dependent, Rap1-
independent pathway for ERK1/2 phosphorylation through
b2-AR, involving Epac, Rap2B, phospholipase C (PLC)e and
Ras-GRP was proposed in HEK293 cells [13]. Indirect support
for a similar pathway was obtained for Gs-coupled serotonin
receptor signalling in PC12 cells [14].
We recently showed that the Ca2+/calmodulin (CaM)-acti-
vated Ras GEF called Ras-GRF1 (CDC25Mm) is expressed
in HEK293 cells and becomes phosphorylated following stim-
ulation of the Gs-coupled serotonin receptor 5-HT7 [15]. We
now expand on these results using HEK293 cells stably and
transiently expressing 5-HT4 receptors to examine the role of
Ca2+, CaM, PLC and Ras-GRF1 in ERK1/2 activation. We
also address the role of the Epac/Rap pathway in ERK1/2
phosphorylation mediated through the Gs-coupled receptors
5-HT4 and b2-AR. The results do not support a role for Epac,
Rap or PLCe in ERK1/2 phosphorylation. However, seroto-
nin-stimulated Ras-GRF1 phosphorylation combined with
Ca2+- and CaM-dependence of the Ras-dependent ERK1/2
phosphorylation is consistent with a role for Ras-GRF1 in
Ras activation mediated through 5-HT4 as well as 5-HT7
receptors [15]. The data imply signiﬁcant diﬀerences in signal-
ling mechanisms between isolates of HEK293 cells.2. Materials and methods
2.1. Plasmids
The pcDNA3.1() vectors encoding human 5-HT4(b) and 5-HT7(a)
receptors [16,17] and the pKH3 mammalian expression vector [18]
encoding murine full-length and truncated HA-Ras-GRF1 [6,15,19]blished by Elsevier B.V. All rights reserved.
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Epac, lacking the cAMP binding domain [10] were kindly provided
by Drs. J.L. Bos and J.M. Enserink, Utrecht, The Netherlands. The se-
quence encoding human b2-adrenoceptor was excised from the plasmid
pAGA-2 [20] with EcoRI and XbaI and transferred to pcDNA3.1(+).2.2. Cell culture and transfection
HEK293 cells stably expressing human 5-HT4(b) receptors (clone
4L13) were established previously [17]. Transient transfections with hu-
man 5-HT4(b) or 5-HT7(a) receptor were done as previously described
for 5-HT7(a) receptors [15]. When indicated, cells were preincubated
with 20 lM 5-amino-1-((3,5-dichloro-4-(4-chlorobenzoyl)phenyl)-
methyl)-1H-1,2,3-triazole-4-carboxamide (CAI) for 25 min or 25 lM
W7 for 15 min prior to agonist treatment (serotonin or isoproterenol,
both at 10 lM for 5 min unless otherwise indicated). Experiments were
carried out in duplicates at least three times. Phospho-ERK1/2 and
phospho-Ras-GRF1 assays, [Ca2+]i measurements in single cells and
Rap pull-down experiments were carried out as described [2].Fig. 1. 5-HT4 receptor stimulation increases [Ca
2+]i and causes Ca
2+-
dependent ERK1/2 phosphorylation. (A) [Ca2+]i recordings in
HEK293 cells stably expressing human 5-HT4(b) receptors, treated2.3. Inositol phosphate accumulation
Cells were labelled with [3H]-inositol (20 Ci/mmol, 5 lCi/well) for
24 h. Fresh medium containing 20 mM LiCl was added 15 min before
stimulation. Total inositol phosphates were determined as described
[21].(arrow) with 5-HT (upper line) or vehicle (lower line). (B) HEK293
cells transiently expressing 5-HT4(b) were treated with CAI prior to
treatment without or with serotonin, as indicated. Western blots were
probed with anti-phospho-ERK1/2 (pERK1/2; upper panel) and then
anti-ERK1/2 antibodies (ERK1/2; lower panel).3. Results
3.1. 5-HT4 receptor stimulation increases [Ca
2+]i and causes
Ca2+-dependent ERK1/2 phosphorylation
Serotonin treatment of HEK293 cells stably expressing 5-
HT4(b) receptors increased [Ca
2+]i (Fig. 1A). Pretreating
HEK293 cells with the calcium inﬂux inhibitor CAI (20 lM)
markedly reduced 5-HT4 receptor-mediated ERK1/2 phos-
phorylation (Fig. 1B). Thus, serotonin increases [Ca2+]i and
causes Ca2+-dependent ERK1/2 phosphorylation through 5-
HT4 receptors in HEK293 cells, in accordance with our previ-
ous ﬁndings with 5-HT7 receptors [15].
3.2. Gs-coupled receptors stimulate ERK1/2 phosphorylation
independently of Epac and Rap
Epac overexpression did not consistently inﬂuence the ERK1/
2 phosphorylation stimulated through transfected 5-HT4 or 5-
HT7 receptors (Fig. 2A), or through endogenous or transfected
b2-AR (Fig. 2B). Overexpression of a constitutively active var-
iant of Epac (DcAMP-Epac) slightly reduced agonist-induced
ERK1/2 phosphorylation in HEK293 cells (Fig. 2A and B).
The Epac-speciﬁc cAMP analogue 8-pCPT-2Me-cAMP, up to
100 lM, did not induce ERK1/2 phosphorylation (Fig. 2C)
although Rap was activated, as conﬁrmed by pull-down exper-
iments (Fig. 2D). Thus, neither Epac nor Rap proteins play
central roles in ERK1/2 phosphorylation in our HEK293 cells.
3.3. Serotonin does not increase inositol phosphate accumulation
Serotonin treatment of HEK293 cells stably expressing 5-
HT4 receptors did not result in increased inositol phosphate
accumulation, whereas carbachol, acting through endogenous
muscarinic acetylcholine receptors, caused substantial increase
(Fig. 3). Thus, 5-HT4 receptors expressed in HEK293 cells do
not activate PLC or increase inositol phosphate levels.
3.4. Forskolin-induced phosphorylation of Ras-GRF1 and
ERK1/2
Forskolin induced Ras-GRF1 phosphorylation after 3 min,
remaining for at least 15 min (Fig. 4A, upper panels). For-skolin-induced ERK1/2 phosphorylation was less sustained
compared to the Ras-GRF1 phosphorylation, with a maxi-
mum after 5 min (Fig. 4A, lower panels). The maximal for-
skolin-induced ERK1/2 phosphorylation was weaker than
serotonin-induced ERK1/2 phosphorylation, but the Ras-
GRF1 phosphorylation was comparable. Pretreatment with
CAI resulted in reduced forskolin-induced ERK1/2 phosphor-
ylation (Fig. 4B).3.5. Serotonin-induced ERK1/2 phosphorylation is sensitive to a
CaM antagonist
Pretreatment with the calmodulin antagonist N-(6-Amin-
ohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride
(W7) reduced the serotonin-induced ERK1/2 phosphorylation
mediated through 5-HT4 receptors (Fig. 5A), but did not inﬂu-
ence the phosphorylation of endogenous Ras-GRF1 (Fig. 5B),
consistent with a role for CaM in serotonin-induced ERK1/2
but not Ras-GRF1 phosphorylation.3.6. An intact N-terminal region is required for Ras-GRF1 to
enhance 5-HT4-mediated ERK1/2 phosphorylation
Cotransfection of HEK293 cells with 5-HT4 receptors and
HA-Ras-GRF1 wt resulted in increased basal and serotonin-
induced ERK1/2 phosphorylation, but a truncated Ras-
GRF1 (HA-Ras-GRF1-D1-225) lacking the PH1-, coiled-coil
and IQ-domains was less eﬀective (Fig. 6A). Other truncated
and mutated Ras-GRF1 versions, retaining mainly the
GEF domain (HA-Ras-GRF1-D1-900, HA-Ras-GRF1-D1-
900,S916A and HA-Ras-GRF1-D1-976), had only minor and
comparable elevating eﬀects on both basal and serotonin-in-
duced ERK1/2 phosphorylation (Fig. 6B). Serotonin-treat-
ment induced detectable phosphorylation of all Ras-GRF1
versions with an intact Ser916 phosphorylation site (Fig. 6).
Fig. 2. Overexpression of Epac or DcAMP-Epac does not increase serotonin-induced ERK1/2 phosphorylation and 8-pCPT-2ME-cAMP does not
cause ERK1/2 phosphorylation. (A) HEK293 cells cotransfected with 5-HT4(b) (upper panels) or 5-HT7(a) (lower panels) and Epac or DcAMP-Epac
were treated without or with serotonin (5-HT). (B) HEK293 cells cotransfected with empty vector (upper panels) or b2-AR (lower panels) and Epac
or DcAMP-Epac were treated without or with 10 lM isoproterenol (Iso). (C) HEK293 cells transiently expressing 5-HT4(b) receptors were treated
with vehicle, serotonin or increasing concentrations of 8-pCPT-2ME-cAMP (C, vehicle). (D) HEK293 cells were treated with serotonin (5-HT4(b)-
transfected cells) or 8-pCPT-2ME-cAMP (10 lM; non-transfected cells) and assayed for Rap1 activation by pull down. Western blots were probed
with antibodies as described for Fig. 1B (A–C) or anti-Rap1 antibodies (D).
Fig. 3. Serotonin does not increase inositol phosphate accumulation.
HEK293 cells stably expressing 5-HT4(b) receptors were labelled with
myo-[2-3H]inositol 24 h prior to treatment with 10 lM serotonin or
carbachol as indicated. Unstimulated inositol phosphate accumulation
(control, Ctr) was 20800 ± 5200 and 24500 ± 7100 dpm/mg protein at
15 and 30 min, respectively. Mean ± S.E.M. of three experiments.
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We ﬁnd that in HEK293 cells serotonin-induced Ras-depen-
dent ERK1/2 phosphorylation mediated through 5-HT4 recep-
tors depends on Ca2+ and is sensitive to a calmodulin
antagonist. Importantly, in the HEK293 cells used, Gs-coupled
receptors activated ERK1/2 independently of Epac or Rap
proteins. These results indicate the existence of a Ca2+- and
Ras-dependent pathway from Gs-coupled receptors to
ERK1/2 phosphorylation independent of Epac and Rap pro-
teins.
In the current study, stimulation of HEK293 cells stably
transfected with 5-HT4(b) receptors increased [Ca
2+]i. In a pre-
vious report, this eﬀect was only observed in the presence of
sodium butyrate [22]. Furthermore, serotonin-induced
ERK1/2 phosphorylation mediated through 5-HT4 receptors
was reduced in the presence of the Ca2+ inﬂux inhibitor CAI
Fig. 6. Ras-GRF1 increases both basal and 5-HT4-mediated ERK1/2
phosphorylation, dependent on the N-terminal domain. HEK293 cells
transfected with 5-HT4(b) receptor and empty vector, full-length HA-
Ras-GRF1 or HA-Ras-GRF1-D1-225 (A) or with 5-HT4(b) receptors
and empty vector, full-length HA-Ras-GRF1, HA-Ras-GRF1-D1-900,
HA-Ras-GRF1-D1-900,916A or HA-Ras-GRF1-D1-976 (B) were
treated with serotonin as indicated. Western blots were probed with
anti-phospho-ERK1/2, anti-ERK1/2, anti-phospho-Ras-GRF1 or anti-
HA-probe as indicated.
Fig. 4. Forskolin-induced phosphorylation of Ras-GRF1 and ERK1/
2. (A) HEK293 cells were treated with vehicle, 10 lM forskolin or
serotonin (5-HT4(b)-expressing cells) as indicated. (B) HEK293 cells
were treated without or with CAI prior to treatment without or with
10 lM forskolin as indicated. Western blots were probed with anti-
phospho-Ras-GRF1, anti-Ras-GRF1, anti-phospho-ERK1/2 or anti-
ERK1/2 as indicated.
Fig. 5. Serotonin-induced ERK1/2 but not Ras-GRF1 phosphoryla-
tion is inhibited by a calmodulin antagonist. HEK293 cells transiently
expressing 5-HT4(b) receptors were pretreated with W7 prior to
serotonin as indicated and analysed for ERK1/2 (A) and Ras-GRF1
(B) phosphorylation as in Fig. 4.
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cate a role for both Ca2+ and CaM in ERK1/2 phosphoryla-
tion through Gs-coupled serotonin receptors.
Recently, a novel pathway including Epac, Rap2B, PLCe
and Ras-GRP in Ras- and Ca2+-dependent ERK1/2 phosphor-
ylation through overexpressed b2-AR in HEK293 cells and
prostaglandin (Pg) E1-receptors in N1E-115 neuroblastoma
cells was reported [13]. In contrast, we found that Epac over-
expression did not consistently increase serotonin- or isoprote-
renol-induced ERK1/2 phosphorylation. Overexpression of a
truncated, constitutively active version of Epac (DcAMP-Epac,
[10]), lacking the cAMP-binding domain, slightly reduced the
ERK1/2 phosphorylation through endogenous and recombi-
nant b2-AR as well as recombinant Gs-coupled serotonin
receptors. This seems consistent with tonic inhibition of Ras-
dependent ERK1/2 phosphorylation through sustained activa-
tion of Rap proteins, resulting from DcAMP-Epac overexpres-
sion. This is in agreement with previously reported eﬀects ofRap1 on Ras signalling [23,24]. However, this model of
Rap1 function has been questioned by others [25].
Many recent papers have addressed the role of Rap in ERK1/
2 activation, but the exact role is still a matter of controversy.
Globally increasing intracellular cAMP levels by forskolin
treatment induced ERK1/2 phosphorylation, but treatment
with the Epac-speciﬁc cAMP analogue 8-pCPT-2Me-cAMP
did not. This strengthens a hypothesis of ERK1/2 phosphoryla-
tion being independent of Epac and Rap proteins. In PC12
cells, Epac overexpression enhanced 5-HT7 receptor-mediated
ERK1/2 phosphorylation, whereas 8-pCPT-2Me-cAMP did
not, except in the presence of an inhibitor of adenylyl cyclase
[14]. In the HEK293 cells used by Keiper and colleagues, 8-
pCPT-2Me-cAMP induced ERK1/2 phosphorylation [13].
The various observed eﬀects of 8-pCPT-2Me-cAMP treatment
and Epac overexpression implicate diﬀerences between cell
types and even between isolates of the apparently same cell
type. This could reﬂect diﬀerences in expression and/or organi-
sation of components of signalling cascades. Previously,
diﬀerences between various HEK293 isolates have been demon-
J.H. Norum et al. / FEBS Letters 581 (2007) 15–20 19strated regarding pertussis toxin-sensitive mechanisms of
ERK1/2 phosphorylation [26]. The diﬀerences in signalling
properties between various HEK293 isolates highlight the diﬃ-
culties of claiming physiological importance of a signalling
pathway characterised in cell lines.
Since 5-HT4 receptor activation did not increase inositol
phosphate levels, a role for Ras-GRP (Cal-DAG-GEF) family
members seems unlikely in the serotonin-induced Ca2+- and
Ras-dependent ERK1/2 phosphorylation. Ras-GRF1 is
another Ca2+-dependent Ras GEF that is expressed in our
HEK293 cells and that may be involved in Ca2+- and Ras-
dependent ERK1/2 phosphorylation [15]. Coexpression of
Ras-GRF1 wt with 5-HT4 receptors increased basal and
serotonin-induced ERK1/2 phosphorylation. Coexpression of
truncated versions of Ras-GRF1, lacking the PH1-, coiled-coil
and IQ-domain or mainly constituting the GEF-domain, was
less eﬀective. This is consistent with Ras-GRF1 requiring acti-
vation by Ca2+/CaM binding to the IQ-domain [27]. The PH1-
and coiled-coil domains also contribute to regulation of Ras
GEF activity and their absence may additionally inﬂuence
the subcellular localisation of HA-Ras-GRF1-D1–225 [28].
Ser916 phosphorylation enhances Ras-GRF1-activity to-
wards Ras [19] and was associated with ERK1/2 phosphoryla-
tion during induction of hippocampal long-term potentiation
[29]. Comparing a truncated wild type and mutated version
of Ras-GRF1, mainly constituting the Ras-GEF domain, we
found no major detectable diﬀerences in the ERK1/2 phos-
phorylation, although we previously showed diﬀerences in
Ras-dependent induction of neurite outgrowth from PC12 cells
[19]. The high basal phosphorylation of HA-Ras-GRF1-D1–
900 could reﬂect altered localisation or loss of regulatory
domains.
Receptor regulation of signalling pathways depends on cel-
lular context. Recombinant systems, with overexpression of
receptors and other signalling components are useful tools in
understanding various aspects of signal transduction when
suitable physiological systems are absent, but high expression
levels and cell type may inﬂuence the results. HEK293 cells
are frequently used as cellular model when addressing signal-
ling pathways, but there are diﬀerences between various iso-
lates of HEK293 cells. Putative receptor-induced signalling
pathways identiﬁed in a recombinant system must eventually
be conﬁrmed in each relevant physiological system. Even
though the pathway(s) leading to ERK1/2 phosphorylation
have been intensively studied for many years, there is constant
debate concerning the involvement of various proteins and
speciﬁc mechanisms in diﬀerent cell types and even in diﬀerent
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